{"nct_id":"NCT01294579","title":"Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL)","status":"COMPLETED","status_verified_date":"2018-08","start_date":"2011-05-17","start_date_type":"ACTUAL","primary_completion_date":"2016-12-20","primary_completion_date_type":"ACTUAL","completion_date":"2016-12-20","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}